Aach J

Chan S

Harris DT

International Society for Stem Cell Research (ISSCR)

Medina Arellano MdJ

Sarah Chan

Taylor NP

US FDA Centre for Biologics Evaluation and Research

English

 Probably the most serious problem facing the field of regenerative medicine today is the challenge of effective translation and development of viable stem cell-based therapies. Particular concerns have been raised over the growing market in unproven cell therapies. In this article, I explore recent developments in the stem cell therapy landscape and argue that while the sale of unproven therapies undoubtedly poses ethical concerns, it must be understood as part of a larger problem at the interface between biomedicine, healthcare, publics, policy and the market. Addressing this will require a broader perspective incorporating the shifting relationships between different stakeholder groups, the global politics of research and innovation, and the evolving role of publics and patients with respect to science. </jats:p

Crossref

Regenerative Medicine

Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation

https://www.pure.ed.ac.uk/ws/files/47046699/rme_2017_0065.pdf

Current and emerging global themes in the bioethics of regenerative medicine:the tangled web of stem cell translation

Current and emerging global themes in the bioethics of regenerative medicine:the tangled web of stem cell translation

Abstract

Similar works

Full text

Available Versions

Crossref